These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31695005)

  • 21. Assessment of Factor XIII.
    Muszbek L; Katona É; Kerényi A
    Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
    Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A
    Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of a fibrin formation abnormality in a case of multiple myeloma.
    Soria J; Soria C; Samama M; Fine JM; Bousser J
    Scand J Haematol; 1975 Oct; 15(3):207-18. PubMed ID: 812173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.
    Biswas A; Ivaskevicius V; Thomas A; Oldenburg J
    Hamostaseologie; 2014; 34(2):160-6. PubMed ID: 24503678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C.
    Sosa R; Gailani D; Neff AT
    Haemophilia; 2014 Nov; 20(6):e429-32. PubMed ID: 25333572
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior of the fibrin-stabilizing blood coagulation factor XIII in hemorrhages after tooth extractions].
    Vogel C
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):137-8. PubMed ID: 6967809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrin cross-linking in congenital factor XIII deficiency.
    Rodeghiero F; Barbui T
    J Clin Pathol; 1980 May; 33(5):434-7. PubMed ID: 7400341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blood coagulation factor XIII and fibrin stabilization (author's transl)].
    Rasche H
    Klin Wochenschr; 1975 Dec; 53(24):1137-45. PubMed ID: 765611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired coagulation factor XIII deficiency: a case report.
    Jia Y; Hu H; Wei B
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):454-6. PubMed ID: 26588447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure.
    Rabik CA; Atkinson MA; Sule S; Strouse JJ
    Transfusion; 2017 Sep; 57(9):2159-2163. PubMed ID: 28707410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.
    Lukacova D; Matsueda GR; Haber E; Reed GL
    Biochemistry; 1991 Oct; 30(42):10164-70. PubMed ID: 1681898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system.
    Lorand L; Velasco PT; Rinne JR; Amare M; Miller LK; Zucker ML
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):232-6. PubMed ID: 3422419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune Hemorrhaphilia Resulting from Autoantibody against the A Subunit of Factor XIII.
    Uchida E; Watanabe K; Arai R; Yamamoto M; Souri M; Osaki T; Ichinose A; Miura O; Koyama T
    Intern Med; 2015; 54(18):2383-7. PubMed ID: 26370866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor XIII deficiency: pathogenic mechanisms and clinical significance.
    Egbring R; Kröniger A; Seitz R
    Semin Thromb Hemost; 1996; 22(5):419-25. PubMed ID: 8989826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An inhibitor of activated factor XIII, inhibiting fibrin cross-linking but not incorporation of amine into casein.
    Godal HC; Ly B
    Scand J Haematol; 1977 Nov; 19(5):443-8. PubMed ID: 594661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor XIII deficiency in BALB/c mice with plasmacytoma.
    Eipe J; Yakulis V; Costea N
    Cancer Res; 1977 Oct; 37(10):3551-5. PubMed ID: 908006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines.
    Souri M; Biswas A; Misawa M; Omura H; Ichinose A
    Haemophilia; 2014 Mar; 20(2):255-62. PubMed ID: 24286209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patients.
    Ichinose A;
    Blood Rev; 2017 Jan; 31(1):37-45. PubMed ID: 27542511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination.
    Luo YY; Zhang GS
    Haemophilia; 2011 May; 17(3):393-8. PubMed ID: 21323797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.